ViS Research (Acquired By IMS Health)

ViS was sold to IMS Health/Quintiles (now IQVIA). ViS Research optimizes clinical trial planning through a structured online feasibility platform. We enable access to a complete map of global clinical research infrastructure, and we focus on the generation and sharing of up-to-date analytics needed for the set up of cost-efficient clinical trials. It is the only platform that enables location selection, site/investigator selection AND engagement in one sitting. Trial planners can finally navigate the intricate, disease-specific decision matrix to directly engage with research centers, without the need for the cumbersome feasibility questionnaires.Trial planning questions can be answered at a small fraction of the time spent and cost incurred through conventional methods. At the same time, ViS enables research centers to create an online profile, which answers over 85 percent of questions raised in feasibility assessments.